Key result
TAVR for aortic insufficiency in healed infective endocarditis currently lacks robust clinical outcome data.
Answers are grounded in this paper and cite their sources.
Aortic insufficiency (AI) frequently persists following resolution of infective endocarditis (IE), yet many patients have prohibitive surgical risk. Data regarding transcatheter aortic valve replacement (TAVR) in this setting remain limited.
No takes yet. Share an insight, caveat, or question.
Maisuradze et al. (2026) studied this question. Transcatheter aortic valve replacement (TAVR) for aortic insufficiency in burned-out infective endocarditis currently has limited outcome data.
Synapse has enriched 10 related papers. Consider them for comparative context: